Cargando…

Celecoxib and acetylbritannilactone interact synergistically to suppress breast cancer cell growth via COX-2-dependent and -independent mechanisms

Mostrar otras versiones (1)

The use of celecoxib is associated with a significant decrease in breast cancer risk. However, the long-term use of high-dose celecoxib might be limited owing to cardiovascular side effects. In this study, we found that acetylbritannilactone (ABL), extract from a Chinese medicinal herb, could reduce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, B, Wen, J K, Li, B H, Fang, X M, Wang, J J, Zhang, Y P, Shi, C J, Zhang, D Q, Han, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199716/ https://www.ncbi.nlm.nih.gov/pubmed/21796157 http://dx.doi.org/10.1038/cddis.2011.64

Ejemplares similares

Celecoxib and acetylbritannilactone interact synergistically to suppress breast cancer cell growth via COX-2-dependent and -independent mechanisms
por: Liu, B, et al.
Publicado: (2011)

Acetylbritannilactone Modulates Vascular Endothelial Growth Factor Signaling and Regulates Angiogenesis in Endothelial Cells
por: Zhao, Jingshan, et al.
Publicado: (2016)

Acetylbritannilactone attenuates contrast-induced acute kidney injury through its anti-pyroptosis effects
por: Chen, Fei, et al.
Publicado: (2020)

The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: An intravital microscopy study in mice
por: Klenke, Frank Michael, et al.
Publicado: (2006)

COX-2 inhibition is neither necessary nor sufficient for celecoxib to suppress tumor cell proliferation and focus formation in vitro
por: Chuang, Huan-Ching, et al.
Publicado: (2008)

Multifocal Fixed Drug Eruption with COX-2 Inhibitor-Celecoxib
por: Chugh, Shikha, et al.
Publicado: (2013)

Celecoxib exerts protective effects in the vascular endothelium via COX-2-independent activation of AMPK-CREB-Nrf2 signalling
por: Al-Rashed, Fahad, et al.
Publicado: (2018)

COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia
por: Farooqui, M, et al.
Publicado: (2007)

Selective COX-2 inhibitors, NSAIDs and cardiovascular events – is celecoxib the safest choice?
por: Howes, Laurence Guy
Publicado: (2007)

Synergistic Effects of Celecoxib and Bupropion in a Model of Chronic Inflammation-Related Depression in Mice
por: Maciel, Izaque S., et al.
Publicado: (2013)

Synergistic Therapy of Celecoxib-Loaded Magnetism-Responsive Hydrogel for Tendon Tissue Injuries
por: Wang, Jingxin, et al.
Publicado: (2020)

Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis
por: Zhou, Ping, et al.
Publicado: (2017)

Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac
por: Walker, Chris
Publicado: (2018)

Correction to: Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis
por: Zhou, Ping, et al.
Publicado: (2021)

The Effects of 1-O-Acetylbritannilactone Isolated from Inula britannica Flowers on Human Neutrophil Elastase and Inflammation of RAW 264.7 Cells and Zebrafish Larvae
por: Lee, Ik Soo, et al.
Publicado: (2023)

Suppressing growth and invasion of human hepatocellular carcinoma cells by celecoxib through inhibition of cyclooxygenase-2
por: Tai, Yang, et al.
Publicado: (2019)

Erratum to “Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac”
por: Walker, Chris
Publicado: (2019)

In Vivo Brain Imaging, Biodistribution, and Radiation Dosimetry Estimation of [(11)C]Celecoxib, a COX-2 PET Ligand, in Nonhuman Primates
por: Kumar, J. S. Dileep, et al.
Publicado: (2018)

Synergistic Analgesia of Duloxetine and Celecoxib in the Mouse Formalin Test: A Combination Analysis
por: Sun, Yong-Hai, et al.
Publicado: (2013)

COX2 inhibition in the treatment of COVID-19: Review of literature to propose repositioning of celecoxib for randomized controlled studies
por: Baghaki, Semih, et al.
Publicado: (2020)

Octreotide and celecoxib synergistically encapsulate VX2 hepatic allografts following transcatheter arterial embolisation
por: TONG, HUAN, et al.
Publicado: (2013)

Evidence for new targets and synergistic effect of metronomic celecoxib/fluvastatin combination in pilocytic astrocytoma
por: Mercurio, Sandy, et al.
Publicado: (2013)

Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats
por: Gao, Jin-Hang, et al.
Publicado: (2016)

ADT‐OH synergistically enhanced the antitumor activity of celecoxib in human colorectal cancer cells
por: Xu, Huangru, et al.
Publicado: (2023)

Cytokinesis-block micronucleus assay of celecoxib and celecoxib derivatives
por: Reimann, Hauke, et al.
Publicado: (2020)

Celecoxib Treatment Alters p53 and MDM2 Expression via COX-2 Crosstalk in A549 Cells
por: Gharghabi, Mehdi, et al.
Publicado: (2016)

Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer
por: Tury, Sandrine, et al.
Publicado: (2016)

Celecoxib, a selective COX-2 inhibitor, markedly reduced the severity of tamoxifen-induced adenomyosis in a murine model
por: Jin, Zhixing, et al.
Publicado: (2020)

Metformin Synergistically Enhanced the Antitumor Activity of Celecoxib in Human Non-Small Cell Lung Cancer Cells
por: Cao, Nini, et al.
Publicado: (2020)

Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN
por: Chu, Tian-Huei, et al.
Publicado: (2013)

Using Celecoxib for the Suppression of Preterm Labor Instead of Magnesium Sulfate
por: Saadati, Najmieh, et al.
Publicado: (2014)

Celecoxib alleviates zinc deficiency-promoted colon tumorigenesis through suppressing inflammation
por: Yin, Xiaolong, et al.
Publicado: (2021)

Cellular and molecular studies of the effects of a selective COX-2 inhibitor celecoxib in the cardiac cell line H9c2 and their correlation with death mechanisms
por: Sakane, K.K., et al.
Publicado: (2013)

Suppressing Growth and Invasion of Human Hepatocellular Carcinoma Cells by Celecoxib Through Inhibition of Cyclooxygenase-2 [Corrigendum]
Publicado: (2021)

Correction: Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats
por: Gao, Jin-Hang, et al.
Publicado: (2022)

Comparative population pharmacokinetics and absolute oral bioavailability of COX-2 selective inhibitors celecoxib, mavacoxib and meloxicam in cockatiels (Nymphicus hollandicus)
por: Dhondt, Laura, et al.
Publicado: (2017)

Celecoxib impairs primary human myoblast proliferation and differentiation independent of cyclooxygenase 2 inhibition
por: Matheny, Ronald W., et al.
Publicado: (2022)

Celecoxib and 2,5‐dimethylcelecoxib inhibit intestinal cancer growth by suppressing the Wnt/β‐catenin signaling pathway
por: Egashira, Issei, et al.
Publicado: (2016)

Celecoxib inhibits growth of tumors in a syngeneic rat liver metastases model for colorectal cancer
por: de Heer, Pieter, et al.
Publicado: (2008)

25-Hydroxycholesterol exerts both a cox-2-dependent transient proliferative effect and cox-2-independent cytotoxic effect on bovine endothelial cells in a time- and cell-type-dependent manner
por: Nguyen, Vicky PKH, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_6k01svr7b670cevq7l2184e4n0